For Linda, it all started with a relentless cough. Then, it became hard for her to breathe. When Linda tested positive for RSV, she didn't know that the virus was more common in people her age. Hear Linda's story about how RSV impacted her life.
Why vaccinate?
RSV stands for respiratory syncytial (sin-SISH-uhl) virus, a highly contagious virus that can affect your lungs and breathing passages. RSV can often begin with mild cold- or flu-like symptoms like coughing, sneezing, or a decrease in appetite. For people aged 60 or older and adults aged 18 to 59 at increased risk, an RSV infection could lead to more serious symptoms like difficulty breathing, high fever, or chest pain. Don’t let RSV get in the way of the good stuff in your life. Protect yourself with mRESVIA.
Effective protection against RSV
mRESVIA is highly effective at preventing severe illness due to RSV in people aged 60 and older and adults aged 18 to 59 who are at increased risk. In a large and diverse clinical trial with over 35,000 participants, mRESVIA was proven to protect adults aged 60 or older against RSV, regardless of preexisting conditions.* A second clinical trial of participants aged 18 to 59 with at least one health condition, including diabetes, asthma, heart disease, and lung disease, showed similar effectiveness.
The most common side effects associated with
mRESVIA include:
- pain at the injection site
- tiredness
- headache
- muscle aches or joint pain
- underarm swelling or tenderness
- chills
- nausea or vomiting
In the clinical studies, most of the side effects resolved within 1 to 2 days.
Savings and coverage
The cost of vaccination with mRESVIA will depend on your insurance coverage, but for most people aged 50 years and older, mRESVIA is expected to be covered by insurance at $0 out-of-pocket. Ask your doctor or pharmacist if mRESVIA is covered.
CDC Recommendations for RSV Vaccinations
To protect against RSV, the CDC recommends vaccinating all adults who are:
- Aged 50 or older at increased risk of severe RSV disease
- Aged 75 years or older
Frequently asked questions
RSV stands for respiratory syncytial (sin-SISH-uhl) virus, a highly contagious virus that can affect your lungs and breathing passages.
RSV is not a new virus, but you may not have heard of it because people often don't get tested for it and don't know they have it. RSV symptoms can be similar to cold and flu symptoms, so unless you get sick enough to go to the hospital with RSV, you are unlikely to be tested.
An analysis of adults aged 60 or older who were hospitalized with either RSV, influenza, or COVID-19 showed that those with RSV infection were more likely to receive supplemental oxygen and admission to the intensive care unit (ICU) compared to patients with COVID-19 or influenza. Fortunately, there are vaccines available for flu, COVID-19, and RSV.
RSV can have lasting consequences, which include worsened preexisting conditions, reduced productivity and/or activity level, weakened cognitive ability, limited independence, and increased length of stay in the hospital.
- Wash hands often with soap and water for at least 20 seconds
- Avoid close contact with others who are sick
- Avoid touching the face, particularly eyes, nose, and mouth
- Clean frequently touched surfaces (such as doorknobs)
Get vaccinated. Vaccination provides protection against RSV. Ask your doctor or pharmacist if vaccination with mRESVIA is right for you.
mRESVIA is a vaccine indicated for the prevention of lower respiratory tract disease and acute respiratory disease caused by respiratory syncytial virus (RSV) in adults aged 60 or older and adults 18 through 59 years of age who are at increased risk for RSV. Click here for a full list of health conditions that can put patients at risk.
The most common side effects associated with mRESVIA include:
- injection site pain
- fatigue
- headache
- muscle or joint pain
- underarm swelling or tenderness
- chills
Overall, mRESVIA was well tolerated with side effects described as mostly mild or moderate. In the clinical study, most of the side effects resolved within 1 to 2 days. Call your doctor or pharmacist if you experience any side effects that do not go away after receiving your RSV vaccination.
Eligible adults can get an mRESVIA vaccine at any time of year.
You don't have to wait to get vaccinated with mRESVIA if you already got your flu or COVID-19 vaccine. mRESVIA is an RSV vaccine that can be given at any time of the year. Ask your doctor or pharmacist about including mRESVIA in your vaccination routine.
Medical conditions such as diabetes, chronic lung or heart disease, and weakened immune systems can cause increased risk for severe RSV. A full list of conditions can be found here.
Information about mRESVIA when you need it
This guide will help you learn more about mRESVIA.
*These conditions included chronic respiratory or heart conditions, advanced liver or kidney diseases, or diabetes.
†Coverage and cost may vary and are subject to change without notice. Reimbursement decisions are made by individual insurance plans.
‡Per the Inflation Reduction Act.
What is mRESVIA and Important Safety Information
What is mRESVIA® (Respiratory Syncytial Virus Vaccine)?
mRESVIA is a vaccine to protect you against lower respiratory tract disease caused by Respiratory Syncytial Virus (RSV).
mRESVIA is for people 60 years of age and older and also for people 18 through 59 years of age who are at increased risk for RSV (people with medical conditions such as diabetes or with diseases affecting the lungs and heart). Vaccination with mRESVIA may not protect all people who receive the vaccine.
mRESVIA does not contain RSV. mRESVIA cannot give you lower respiratory tract disease caused by RSV.
IMPORTANT SAFETY INFORMATION
Who should not get mRESVIA?
You should not get mRESVIA if you had a severe allergic reaction to any ingredient in mRESVIA.
What should you tell your healthcare provider? Tell your healthcare provider about all of your medical conditions, including if you:
- Have any allergies
- Had a severe allergic reaction after receiving a previous dose of any other vaccine
- Have a fever
- Have a bleeding disorder or are on a blood thinner
- Are immunocompromised or are on a medicine that affects your immune system
- Have received any other RSV vaccine
- Have ever fainted in association with an injection
How is mRESVIA given?
mRESVIA is given as an injection into the muscle.
What are the risks of mRESVIA? There is a very small chance that mRESVIA could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of mRESVIA. For this reason, your healthcare provider may ask you to stay for a short time at the place where you received your vaccine. Signs of a severe allergic reaction may include:
- Trouble breathing
- Swelling of your face and throat
- A fast heartbeat
- A rash all over your body
- Dizziness and weakness
Side effects that have been reported in clinical trials with mRESVIA include:
- Injection-site reactions: pain, underarm swelling or tenderness in the same arm of the injection, swelling (hardness), and redness
- Fatigue, headache, muscle pain, joint pain, chills, nausea or vomiting, fever and hives
These may not be all of the possible side effects of mRESVIA. Ask your healthcare provider about any side effects that concern you. You may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or https://vaers.hhs.gov.
Please click for mRESVIA Full Prescribing Information.
© 2025 Moderna US-RSV-2400013 06/2025